Analytical Data
-
Gene name
C14orf143
- Application
-
Alternative Names
EF-hand calcium-binding domain-containing Protein 11
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BUY7
-
Expression Region
1-163 aa
-
AA Sequence
MFFSEARARSRTWEASPSEHRKWVEVFKACDEDHKGYLSREDFKTAVVMLFGYKPSKIEVDSVMSSINPNTSGILLEGFLNIVRKKKEAQRYRNEVRHIFTAFDTYYRGFLTLEDFKKAFRQVAPKLPERTVLEVFREVDRDSDGHVSFRDFEYALNYGQKEA
-
Molecular Weight
45.6 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C14orf143, also known as "Chromosome 14 Open Reading Frame 143," is a protein-coding gene located on chromosome 14, and it has garnered attention in the context of various biological and disease-related studies. Research into C14orf143 has revealed its potential role in cellular processes, including cell proliferation, differentiation, and apoptosis. Recent investigations have indicated that the expression levels of C14orf143 may vary in different tissues and during specific developmental stages, suggesting that it could be involved in tissue-specific functions. Additionally, altered expression of this gene has been associated with certain diseases, including cancer, where it may influence tumorigenesis and progression. The study of C14orf143 recombinantly expressed proteins has allowed researchers to delve deeper into its functional characteristics, enabling the examination of its interactions with other cellular components and its downstream effects in signal transduction pathways. Understanding the molecular mechanisms underlying C14orf143's function could offer insights into its potential as a therapeutic target or biomarker for diseases. Thus, the recombinant expression and characterization of C14orf143 are vital for advancing our knowledge of its biological significance and exploring its implications in health and disease.
